Natalie Grover

Assistant Professor

University of North Carolina at Chapel Hill School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Natalie Grover is an Assistant Professor at the University of North Carolina School of Medicine in the United States. Her research focuses on advanced therapies for hematological malignancies, with recent articles examining the efficacy of CAR-T therapies and their real-world outcomes in various lymphomas. Key areas of her work include aggressive T-cell lymphomas, autoimmune disease interactions, and the evaluation of prognostic markers in lymphoid tumors.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

Priyanka Pophali

Assistant Professor

University of Wisconsin-Madison

UNITED STATES

View details

Geoffrey Shouse

Assistant Clinical Professor

City Of Hope National Medical Center

UNITED STATES

View details

Mazyar Shadman

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Reem Karmali

Assistant Professor

Northwestern University

UNITED STATES

View details

William Wood

Assistant Professor of Medicine

University of North Carolina at Chapel Hill

UNITED STATES

View details

Eric Mou

Clinical Assistant Professor

University of Iowa Hospitals and Clinics

UNITED STATES

View details

Narendranath Epperla

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

Robert Hagan

Assistant Professor

University of North Carolina

UNITED STATES

View details

Fabiana Perna

Indiana University School of Medicine

UNITED STATES

View details

Deborah Stephens

Assistant Professor

Huntsman Cancer Institute

UNITED STATES

View details

Jeffrey Switchenko

Emory University

UNITED STATES

View details

Nausheen Ahmed

Assistant Professor

University of Kansas Medical Center

UNITED STATES

View details

Daniel Peters

Assistant Professor

Augusta University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Natalie Grover

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis

Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV‐CHEP) for the treatment of aggressive adult T‐cell leukaemia/lymphoma

Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART

Can less differentiation drive CARs to success?

CD19-directed CART Therapy for T cell/Histiocyte Rich Large B-cell Lymphoma

Race and insurance: real-world insights on CAR-T outcomes

T-cell lymphoma: the CAR-T revolution is coming

CARs for Hodgkin: engine fine-tuning is in order

Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study

Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies

Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant

How I approach optimization of patients at risk of cardiac and pulmonary complication after CAR-T cell therapy

Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

Building safety into CAR-T therapy

The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Utility of a safety switch to abrogate CD19.CAR T-cell–associated neurotoxicity

Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma

Extending the Promise of Chimeric Antigen Receptor T-Cell Therapy Beyond Targeting CD19+ Tumors

Collaborators (13)

Priyanka Pophali

Geoffrey Shouse

Mazyar Shadman

Reem Karmali

William Wood

Eric Mou

Narendranath Epperla

Robert Hagan

Fabiana Perna

Deborah Stephens

Jeffrey Switchenko

Nausheen Ahmed

Daniel Peters

Make your next move.